מיטומיצין סי 2 מג

Pajjiż: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

MITOMYCIN C ( CRYSTALLINE )

Disponibbli minn:

DEXCEL LTD, ISRAEL

Kodiċi ATC:

L01DC03

Għamla farmaċewtika:

אבקה להכנת תמיסה לזריקה

Kompożizzjoni:

MITOMYCIN C ( CRYSTALLINE ) 2 MG/VIAL

Rotta amministrattiva:

תוך-ורידי, תוך-בטני, לתוך שלפוחית השתן, תוך-עורקי, לתוך קרום הריאה, תוך-שדרתי

Tip ta 'preskrizzjoni:

מרשם נדרש

Manifatturat minn:

KYOWA HAKKO KIRIN CO. LTD., JAPAN

Grupp terapewtiku:

MITOMYCIN

Żona terapewtika:

MITOMYCIN

Indikazzjonijiet terapewtiċi:

Remission of subjective and objective symptoms assocciated with the following diseases: Chronic lymphocytic leukemia, chronic myelocytic leukemia, gastric cancer, colorectal cancer, lung cancer, pancreatic cancer, liver cancer, cervix cancer, cancer of the endometrium, breast cancer, head and neck tumor and bladder tumor.

Data ta 'l-awtorizzazzjoni:

2014-06-30